| Pancreatitis Pathology and Treatment | Lifetime | 31 | NL 2 | 99.72 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 77 | NL 5 | 99.71 |
| Gastrointestinal disorders and treatments | Lifetime | 52 | NL 4 | 99.66 |
| Gallbladder and Bile Duct Disorders | Lifetime | 68 | NL 7 | 99.57 |
| Esophageal and GI Pathology | Lifetime | 154 | NL 14 | 99.34 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 153 | NL 10 | 98.90 |
| Medical Device Sterilization and Disinfection | Lifetime | 23 | NL 2 | 98.01 |
| Esophageal Cancer Research and Treatment | Lifetime | 324 | NL 31 | 98.18 |
| Gastric Cancer Management and Outcomes | Lifetime | 778 | NL 43 | 98.48 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 664 | NL 12 | 97.52 |
| Abdominal vascular conditions and treatments | Lifetime | 188 | NL 5 | 96.17 |
| Biliary and Gastrointestinal Fistulas | Lifetime | 212 | NL 11 | 96.46 |
| Colorectal Cancer Screening and Detection | Lifetime | 801 | NL 49 | 97.26 |
| Intestinal Malrotation and Obstruction Disorders | Lifetime | 566 | NL 19 | 92.75 |
| Healthcare cost, quality, practices | Lifetime | 713 | NL 34 | 92.56 |
| Foreign Body Medical Cases | Lifetime | 564 | NL 11 | 83.48 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 774 | NL 21 | 82.46 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 13 | NL 3 | 99.38 |
| Gastrointestinal disorders and treatments | 2021-2025 | 11 | NL 1 | 98.58 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 37 | NL 6 | 99.41 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 15 | NL 4 | 99.37 |
| Medical Device Sterilization and Disinfection | 2021-2025 | 1 | NL 1 | 99.16 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 62 | NL 6 | 96.98 |
| Esophageal and GI Pathology | 2021-2025 | 141 | NL 20 | 97.54 |
| Healthcare cost, quality, practices | 2021-2025 | 46 | NL 1 | 95.30 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 279 | NL 11 | 95.09 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 705 | NL 39 | 91.14 |
| Infection Control in Healthcare | 2021-2025 | 60 | NL 3 | 88.62 |
| Abdominal vascular conditions and treatments | 2021-2025 | 76 | NL 3 | 84.45 |
| Quality and Safety in Healthcare | 2021-2025 | 80 | NL 1 | 83.18 |
| Biliary and Gastrointestinal Fistulas | 2021-2025 | 230 | NL 10 | 79.94 |
| Intestinal Malrotation and Obstruction Disorders | 2021-2025 | 444 | NL 36 | 68.21 |
| Gastrointestinal Bleeding Diagnosis and Treatment | 2021-2025 | 977 | NL 11 | 61.08 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 887 | NL 18 | 40.21 |
